BULLOUS PEMPHIGOID (BP)

Clinical trials for BULLOUS PEMPHIGOID (BP) explained in plain language.

Never miss a new study

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

Sign up with your email to follow new studies for BULLOUS PEMPHIGOID (BP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New drug trial offers hope for painful skin blistering disease

Disease control Not yet recruiting

This study is testing whether an injectable drug called stapokibart can help control moderate to severe bullous pemphigoid, a condition that causes painful, itchy skin blisters. Researchers will compare stapokibart against a placebo (inactive injection) in 200 adults to see if it…

Matched conditions: BULLOUS PEMPHIGOID (BP)

Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

BULLOUS PEMPHIGOID (BP)

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

New drug trial offers hope for painful skin blistering disease